Contact
Hoppe-Seyler-Strasse 3
72076 Tübingen
Germany
2022
- N. Harland et al., “Elevated Expression of the Immune Checkpoint Ligand CD276 (B7-H3) in Urothelial Carcinoma Cell Lines Correlates Negatively with the Cell Proliferation,” International Journal of Molecular Sciences, vol. 23, no. 9, Art. no. 9, 2022, doi: 10.3390/ijms23094969.
- L. Becker et al., “Data-Driven Identification of Biomarkers for In Situ Monitoring of Drug Treatment in Bladder Cancer Organoids,” International Journal of Molecular Sciences, vol. 23, no. 13, Art. no. 13, 2022, doi: 10.3390/ijms23136956.
- Y. Wei et al., “Urinary Tract Tumor Organoids Reveal Eminent Differences in Drug Sensitivities When Compared to 2-Dimensional Culture Systems,” International Journal of Molecular Sciences, vol. 23, no. 11, Art. no. 11, 2022, doi: 10.3390/ijms23116305.
- R. Geng et al., “CD24: A Marker for an Extended Expansion Potential of Urothelial Cancer Cell Organoids In Vitro?,” International Journal of Molecular Sciences, vol. 23, no. 10, Art. no. 10, 2022, doi: 10.3390/ijms23105453.
2021
- N. Harland et al., “Organoide zur Weiterentwicklung der intraoperativen Diagnostik,” Der Urologe, vol. 60, no. 9, Art. no. 9, Sep. 2021, doi: 10.1007/s00120-021-01595-5.
Akademische Ausbildung und beruflicher Werdegang
- 1980 - 1985 Studies in Biochemistry and Physiological Chemistry at the University of Tübingen and at Ludwigs-Maximilians University, Munich
- 1985 - 1986 Diploma Thesis, University of Tübingen and Max-Planck Institute for Developmental Biology, Tübingen
- 1986 - 1989 PhD student at Max-Planck Institute for Biology, Tübingen
- 1987 - 1989 Research Fellow, Department of Microbiology, University of Alabama at Birmingham (UAB), Birmingham, AL. USA
- 1990 PhD, Faculty of Biology at University of Tübingen
- 1990 - 1991Research Associate, Division of Rheumatology, WHO Rheumatology Research Center at UAB, Birmingham, AL. USA
- 1992 - 1996 Research Assistant, Clinical Rheumatology Research Group University of Freiburg Hospital, Freiburg
- 1997 - 2011 Head of Research Laboratory, Dept. of Orthopopedic Surgery University of Tübingen Hospital, Tübingen
- 1999 Habilitation and venia legendi at Faculty of Medicine, Eberhard-Karls University, Tübingen
- 2005 - 2013 Assoc. Prof. for Molecular Medicine (apl. Prof.), Centre for Medical Research, University of Tübingen Medical School 2006 - 2011 Deputy Director, Centre for Regeneration Biology and Medical Technology, at University of Tübingen
- 2006 - 2011 Deputy Director, Centre for Regeneration Biology and Medical Technology, at University of Tübingen
- 2012 - 2015 Head of KFO273, Medical Faculty, Eberhard-Karls University, Tübingen
- 2013 - 2017 Coordinator of COST Action BM1209 Regenerative Sphincter Therapy ( ReST )
- 2014 - present Professor for Experimental Urology, Head of Research Laboratories, Dept. of Urology, University of Tübingen Hospital
- 2017 - 2020 Management Committee, COST Action ENIUS; file # CA16217)
